In addition, mitapivat clinical trial protocols across all indications have been updated to incorporate similar monitoring. “Informed by the robust data from both the Phase 3 ENERGIZE and ENERGIZE-T ...
Six Republican senators in a letter to National Institutes of Health (NIH) Director Monica Bertagnolli said they are ...
The University of Cincinnati’s Ishita Basu, PhD, has been awarded an $810,000 United States Department of Defense grant to ...
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...
In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...
Digitalisation and AI in Orthopedic Surgery and Rehabilitation 4.0', and the rapidly evolving subject area, we are pleased to ...
Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...
WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the ...
For people battling cancer, getting a chance to take part in a research trial of a new treatment can sometimes make a big difference. Starting next year, patients at the Avera Cancer Institute in ...